Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Healthy Heart Study: Insulin Glargine vs Metformin in T2D with CAD
NCT01035528Phase 4Unknown
- Sponsor
- München Klinik
- Start
- Apr 2005
- Primary completion
- Feb 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by München Klinik. Primary endpoint: change from baseline to endpoint in myocardial diastolic velocity E' at 24 weeks. Status: unknown.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01035528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01035528.